At 1:54 ET on Saturday afternoon, New York Yankees play-by-play man Michael Kay lit the fuse on what will be remembered as either one of the most metamorphic conversations in baseball history or one o...
After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was expected to be a shoo-in. Lykos,...
